BioCentury
ARTICLE | Company News

Merck returning S1P receptor agonist to Ono

June 18, 2014 12:50 AM UTC

Merck KGaA (Xetra:MRK) is returning rights to Ono Pharmaceutical Co. Ltd. (Tokyo:4528) for ceralifimod ( ONO-4641), a sphingosine 1-phosphate (S1P) receptor agonist in development for multiple scleros...